Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Agenus
Pharma
Unable to 'align' with FDA, Regeneron, Sanofi pull Libtayo BLA
Unable to "align on certain post-marketing studies," with the FDA, Regeneron and Sanofi have pulled their application for Libtayo in cervical cancer.
Kevin Dunleavy
Jan 28, 2022 9:30am
MaxiVAX, PATH and more—News of Note
Jul 17, 2018 3:20pm
Pfizer, Merck KGaA join with Vaximm for Bavencio combo studies
May 9, 2017 3:35pm
Keytruda set for cancer vaccine combo trial in glioblastoma
Jan 17, 2017 2:54pm
Genocea armed with positive phase 2b data on herpes vax
Jan 10, 2017 10:43am
